T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EDR
601
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $74.6M | 0.01% |
3,143,939
-1,000,528
| -24% | -$22.6M |
|
602
Simpson Manufacturing
SSD
$8B
| $74.1M | 0.01% |
374,118
+81,711
| +28% | +$13M |
|
603
Xencor
XNCR
$1.71B
| $74M | 0.01% |
3,483,775
+298,841
| +9% | +$5.69M |
|
604
Zai Lab
ZLAB
$2.92B
| $73.9M | 0.01% |
2,704,455
-12,139
| -0.4% | -$320K |
|
605
Aflac
AFL
$60.7B
| $71.8M | 0.01% |
870,549
+3,343
| +0.4% | +$269K |
|
606
Performance Food Group
PFGC
$16.4B
| $71.8M | 0.01% |
1,038,045
-30,271
| -3% | -$1.86M |
|
607
Sarepta Therapeutics
SRPT
$1.95B
| $71.3M | 0.01% |
739,736
-48,220
| -6% | -$4.63M |
|
608
Atkore
ATKR
$3.17B
| $71.1M | 0.01% |
444,471
-39,199
| -8% | -$5.41M |
|
609
Eagle Materials
EXP
$6.41B
| $70.5M | 0.01% |
347,361
-1,854
| -0.5% | -$326K |
|
610
PPG Industries
PPG
$25.5B
| $70.4M | 0.01% |
470,605
+3,684
| +0.8% | +$499K |
|
611
Watts Water Technologies
WTS
$12.8B
| $70.3M | 0.01% |
337,329
-4,323
| -1% | -$816K |
|
|
ACLX
612
DELISTED
Arcellx
ACLX
| $69.9M | 0.01% |
1,260,180
+323,309
| +35% | +$14.6M |
|
613
Coca-Cola Consolidated
COKE
$12.7B
| $69.7M | 0.01% |
750,730
-4,790
| -0.6% | -$347K |
|
614
ResMed
RMD
$32.9B
| $69.6M | 0.01% |
404,853
-14,877
| -4% | -$2.29M |
|
|
AXON
615
Axon Enterprise
AXON
$50B
| $69.1M | 0.01% |
267,518
+36,948
| +16% | +$8.33M |
|
616
CACI
CACI
$14.8B
| $68.9M | 0.01% |
212,779
-17,391
| -8% | -$5.64M |
|
617
Pliant Therapeutics
PLRX
$66.9M
| $68.6M | 0.01% |
3,785,916
+434,429
| +13% | +$6.61M |
|
618
Structure Therapeutics
GPCR
$3.89B
| $68.5M | 0.01% |
1,679,436
-834,127
| -33% | -$47.8M |
|
619
ZTO Express
ZTO
$17.4B
| $68.3M | 0.01% |
3,211,473
+3,197,073
| +22,202% | +$72.6M |
|
620
Nexstar Media Group
NXST
$5.81B
| $68.2M | 0.01% |
435,052
+4,823
| +1% | +$706K |
|
621
Sanofi
SNY
$105B
| $67.5M | 0.01% |
1,357,697
+14,358
| +1% | +$702K |
|
622
Immunovant
IMVT
$8.64B
| $67.5M | 0.01% |
1,602,562
+872,520
| +120% | +$32.1M |
|
|
SGI
623
Somnigroup International
SGI
$14B
| $67.1M | 0.01% |
1,316,350
+68,646
| +6% | +$2.91M |
|
624
BellRing Brands
BRBR
$1.28B
| $66.8M | 0.01% |
1,204,695
+20,640
| +2% | +$995K |
|
|
JOYY
625
JOYY Inc
JOYY
$3.64B
| $66.8M | 0.01% |
1,681,500
+24,875
| +2% | +$989K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.